List of works - Maria Paola Trotta

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens

scientific article published in May 2003

Beyond virological suppression: the role of adherence in the late HAART era.

scientific article published on 13 March 2012

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

article

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

scientific article published in August 2004

Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature

scientific article

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy

scientific article

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

article

Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy

scientific article

Dynamics of NRTI Resistance Mutations during Therapy Interruption

article

Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine

scientific article published on 26 October 2007

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

scientific article published on 13 April 2004

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

scientific article

Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

scientific article

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

scientific article

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

scientific article published in August 2010

Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.

scientific article published in April 2004

Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

scientific article published on 20 June 2012

Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals

article

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

article

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

scientific article published in December 2003

Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy

scientific article published in December 2011

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

scientific article published on 05 January 2009

Treatment-related factors and highly active antiretroviral therapy adherence

scientific article

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

scientific article published in February 2003

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance

scientific article published on 22 May 2003

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

scientific article

Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation

scientific article published in January 2007

List of works by Maria Paola Trotta

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens

Beyond virological suppression: the role of adherence in the late HAART era.

Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.

Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome

Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy

Dynamics of NRTI Resistance Mutations during Therapy Interruption

Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort

Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors

Patient-reported and physician-estimated adherence to HAART: social and clinic center-related factors are associated with discordance.

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures

Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART.

Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

Self-Reported Sexual Dysfunction Is Frequent Among HIV-Infected Persons and Is Associated with Suboptimal Adherence to Antiretrovirals

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy

Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

Treatment-related factors and highly active antiretroviral therapy adherence

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation